Methods And Compositions For Preventing Or Reducing The Risk Of Cancer Treatment-Related Cardiotoxicity


Ontology type: sgo:Patent     


Patent Info

DATE

2017-12-28T00:00

AUTHORS

DAHLÖF, Björn , LJUNGGREN, ANDERS , ERMIS, Necip

ABSTRACT

The present invention relates to a new use of compounds that are angiotensin II (Ang II) agonists, more particularly agonists of the Ang II type 2 receptor (the AT2 receptor), and especially agonists that bind selectively to the AT2 receptor, for prevention or reduction of the risk of cancer treatment-related cardiotoxicity More... »

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3142", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "DAHL\u00d6F, Bj\u00f6rn", 
        "type": "Person"
      }, 
      {
        "name": "LJUNGGREN, ANDERS", 
        "type": "Person"
      }, 
      {
        "name": "ERMIS, Necip", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1161/circulationaha.108.784868", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004998931"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11906-012-0291-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013882267", 
          "https://doi.org/10.1007/s11906-012-0291-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1517/13543784.2012.664131", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033921265"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/hypertensionaha.111.180158", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051585828"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/hypertensionaha.111.180158", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051585828"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-12-28T00:00", 
    "description": "

The present invention relates to a new use of compounds that are angiotensin II (Ang II) agonists, more particularly agonists of the Ang II type 2 receptor (the AT2 receptor), and especially agonists that bind selectively to the AT2 receptor, for prevention or reduction of the risk of cancer treatment-related cardiotoxicity

", "id": "sg:patent.WO-2017221012-A1", "keywords": [ "composition", "cancer treatment", "invention", "compound", "angiotensin II", "Ang II", "agonist", "Ang", "receptor", "AT2 receptor", "prevention", "reduction", "risk" ], "name": "METHODS AND COMPOSITIONS FOR PREVENTING OR REDUCING THE RISK OF CANCER TREATMENT-RELATED CARDIOTOXICITY", "sameAs": [ "https://app.dimensions.ai/details/patent/WO-2017221012-A1" ], "sdDataset": "patents", "sdDatePublished": "2019-04-18T10:21", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-uberresearch-data-patents-target-20190320-rc/data/sn-export/402f166718b70575fb5d4ffe01f064d1/0000100128-0000352499/json_export_01634.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.WO-2017221012-A1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.WO-2017221012-A1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.WO-2017221012-A1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.WO-2017221012-A1'


 

This table displays all metadata directly associated to this object as RDF triples.

54 TRIPLES      14 PREDICATES      30 URIs      21 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.WO-2017221012-A1 schema:about anzsrc-for:3142
2 schema:author N03612fbab02b47c5b0f74558c3c24d22
3 schema:citation sg:pub.10.1007/s11906-012-0291-6
4 https://doi.org/10.1161/circulationaha.108.784868
5 https://doi.org/10.1161/hypertensionaha.111.180158
6 https://doi.org/10.1517/13543784.2012.664131
7 schema:datePublished 2017-12-28T00:00
8 schema:description <p num="0000">The present invention relates to a new use of compounds that are angiotensin II (Ang II) agonists, more particularly agonists of the Ang II type 2 receptor (the AT2 receptor), and especially agonists that bind selectively to the AT2 receptor, for prevention or reduction of the risk of cancer treatment-related cardiotoxicity</p>
9 schema:keywords AT2 receptor
10 Ang
11 Ang II
12 agonist
13 angiotensin II
14 cancer treatment
15 composition
16 compound
17 invention
18 prevention
19 receptor
20 reduction
21 risk
22 schema:name METHODS AND COMPOSITIONS FOR PREVENTING OR REDUCING THE RISK OF CANCER TREATMENT-RELATED CARDIOTOXICITY
23 schema:sameAs https://app.dimensions.ai/details/patent/WO-2017221012-A1
24 schema:sdDatePublished 2019-04-18T10:21
25 schema:sdLicense https://scigraph.springernature.com/explorer/license/
26 schema:sdPublisher Nff564c6584c948d180ac54c7f2011357
27 sgo:license sg:explorer/license/
28 sgo:sdDataset patents
29 rdf:type sgo:Patent
30 N03612fbab02b47c5b0f74558c3c24d22 rdf:first Ne83e4ed4373b42779686d40a49c6a6c4
31 rdf:rest Nc049b68a4033434ba389afc127c7036b
32 N43b95ecd3fea4d599c1485f531511124 rdf:first Ndb33f3707b5b416ca82f5155793aaecd
33 rdf:rest rdf:nil
34 Nba366d7ea9724844af848ab78c7f56bb schema:name LJUNGGREN, ANDERS
35 rdf:type schema:Person
36 Nc049b68a4033434ba389afc127c7036b rdf:first Nba366d7ea9724844af848ab78c7f56bb
37 rdf:rest N43b95ecd3fea4d599c1485f531511124
38 Ndb33f3707b5b416ca82f5155793aaecd schema:name ERMIS, Necip
39 rdf:type schema:Person
40 Ne83e4ed4373b42779686d40a49c6a6c4 schema:name DAHLÖF, Björn
41 rdf:type schema:Person
42 Nff564c6584c948d180ac54c7f2011357 schema:name Springer Nature - SN SciGraph project
43 rdf:type schema:Organization
44 anzsrc-for:3142 schema:inDefinedTermSet anzsrc-for:
45 rdf:type schema:DefinedTerm
46 sg:pub.10.1007/s11906-012-0291-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013882267
47 https://doi.org/10.1007/s11906-012-0291-6
48 rdf:type schema:CreativeWork
49 https://doi.org/10.1161/circulationaha.108.784868 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004998931
50 rdf:type schema:CreativeWork
51 https://doi.org/10.1161/hypertensionaha.111.180158 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051585828
52 rdf:type schema:CreativeWork
53 https://doi.org/10.1517/13543784.2012.664131 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033921265
54 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...